Stock Events

Stock Events

Aibotics 

$0.02
8
-$0.01-36.03% Friday 20:00

Statistics

Day High
0.03
Day Low
0.03
52W High
0.18
52W Low
0.01
Volume
73,920
Avg. Volume
127,217
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30SepExpected
Q4 2019
Q1 2020
Q2 2020
Q4 2020
Q1 2021
Q2 2021
-0.17
-0.12
-0.06
0
Expected EPS
N/A
Actual EPS
-0.1749

Financials

-Profit Margin
Unprofitable
2018
2019
2020
2021
0Revenue
-2.82MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TPIA. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap606.35M
Compass Pathways operates in the psychedelic medicine space, focusing on psilocybin therapy for mental health conditions, directly competing with Mycotopia's psychedelic therapy initiatives.
AtaiBeckley
ATAI
Mkt Cap1.56B
ATAI Life Sciences is a biotech company with a focus on psychedelic and non-psychedelic compounds for mental health, making it a direct competitor in the psychedelic therapy market.
GH Research
GHRS
Mkt Cap888.26M
GH Research PLC focuses on developing 5-MeO-DMT therapies for treatment-resistant depression, competing in the same psychedelic therapy space as Mycotopia.
Cybin Inc
CYBN
Mkt Cap200.49M
Cybin Inc. is developing psychedelic compounds for various mental health conditions, positioning it as a competitor in the psychedelic-based therapeutic sector.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness Inc. is involved in psychedelic production and therapy, including psilocybin and MDMA, competing in the same market as Mycotopia Therapies.
Revive Therapeutics
RVVTF
Mkt Cap4.68M
Revive Therapeutics Ltd. explores the use of psychedelics in treatments, including psilocybin for substance abuse, a market Mycotopia Therapies is also targeting.

About

Mycotopia Therapies, Inc. focuses on psychedelics for the treatment of mental health issues. It provides psychedelic therapies for the treatment of post-traumatic stress disorder, severe anxiety, depression, palliative care, and serotonin syndrome. The company is based in Aventura, Florida. Mycotopia Therapies, Inc. is a subsidiary of EHAVE, Inc.
Show more...
CEO
Mr. Benjamin Kaplan
Employees
1
Country
US
ISIN
US62846W1071

Listings

OTC Link
US
AIBT

0 Comments

Share your thoughts

FAQ

What is Aibotics stock price today?▼
The current price of TPIA is $0.02 USD — it has decreased by -36.03% in the past 24 hours. Watch Aibotics stock price performance more closely on the chart.
What is Aibotics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Aibotics stocks are traded under the ticker TPIA.
What were Aibotics earnings last quarter?▼
TPIA earnings for the last quarter are -0.17 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Aibotics revenue for the last year?▼
Aibotics revenue for the last year amounts to 0 USD.
What is Aibotics net income for the last year?▼
TPIA net income for the last year is -2.82M USD.
How many employees does Aibotics have?▼
As of April 01, 2026, the company has 1 employees.
In which sector is Aibotics located?▼
Aibotics operates in the Health Care sector.
When did Aibotics complete a stock split?▼
Aibotics has not had any recent stock splits.
Where is Aibotics headquartered?▼
Aibotics is headquartered in Miami, US.